Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields

During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.

Pfizer Inc. (NYSE:PFE)

• Dividend Yield: 5.81%
• Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating with a price target of $45 on July 10. This analyst has an accuracy rate of 70%.
• BMO Capital analyst Evan David Seigerman reiterated an Outperform rating and raised the price target from $33 to $36 on May 2. This analyst has an accuracy rate of 70%.
• Recent News: On July 11, Pfizer announced it selected its preferred once-daily modified release formulation for danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist.
• Benzinga Pro's real-time newsfeed alerted to latest Pfizer's news

CVS Health Corporation (NYSE:CVS)

• Dividend Yield: 4.51%
• Argus Research analyst Chris Graja maintained a Buy rating and cut the price target from $100 to $80 on May 8. This analyst has an accuracy rate of 70%.
• Truist Securities analyst David Macdonald reiterated a Buy rating and lowered the price target from $90 to $66 on May 2. This analyst has an accuracy rate of 71%.
• Recent News: CVS Health said it will report second-quarter financial results on Wednesday, Aug. 7.
• Benzinga Pro's charting tool helped identify the trend in CVS stock.

Medtronic plc (NYSE:MDT)

• Dividend Yield: 3.59%
• Wells Fargo analyst Larry Biegelsen maintained an Overweight rating and raised the price target from $102 to $105 on May 24. This analyst has an accuracy rate of 73%.
• Mizuho analyst Anthony Petrone maintained a Buy rating and increased the price target from $95 to $98 on Feb. 21. This analyst has an accuracy rate of 65%.
• Recent News: On June 26, Medtronic announced the resignation of EVP and CFO Karen Parkhill.
• Benzinga Pro's signals feature notified of a potential breakout in Medtronic's shares.

Read More:

• How To Earn $500 A Month From Bank of America Stock Ahead Of Q2 Earnings